Ardelyx, Inc. (ARDX)
$3.28+0.31%Close
SELLBEAR · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $810M
- Beta
- 0.68
- P/E (TTM)
- -14.67
- Short % float
- 11.67%
- Days to cover
- 6.6
- SI change
- +8.1%
- 1W
- -1.80%
- 1M
- -9.39%
- vs SPY 1W
- -2.96%
- vs SPY 1M
- -12.38%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$8.1BCRISISQ 10$92.72+7.25%
- PHVSSELLPharvaris N.V.$2.1BCRISISQ 15$30.49-0.06%
- BCRXSELLBioCryst Pharmaceuticals, Inc.$2.1BRECOVERYQ 6$8.10+3.14%
- TRVISELLTrevi Therapeutics, Inc.$1.9BCRISISQ 19$13.72+2.81%
- ZYMESELLZymeworks Inc.$1.9BBEARQ 12$26.21+2.10%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 4$12.75+3.73%
- STOKSELLStoke Therapeutics, Inc.$1.6BCRISISQ 11$25.32+3.30%
- MAZEBUYMaze Therapeutics, Inc.$1.5BRECOVERYQ 36$26.43+4.75%
- WVESELLWave Life Sciences Ltd.$739MCRISISQ 7$3.75-0.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
